ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market Jun 30, 2023
ZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient May 30, 2023
ZIVO Bioscience Announces Results of Study with its Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens Feb 10, 2023
ZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech Business Oct 24, 2022
Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq Apr 25, 2022
